Vaccine not Australia’s COVID transmission ‘silver bullet’ A new report informed by leading experts urges a multi-pronged response to the pandemic in 2021. But what does that look like?
How will GPs tackle COVID vaccine hesitancy? Events like this week’s abandoned University of Queensland trial are unlikely to inspire confidence in people with questions about the safety of a COVID vaccine.
Peer-reviewed AstraZeneca data raises questions over vaccine rollout Publication of the highly anticipated data has highlighted the need for further trials to confirm dosage and efficacy.
Australian coronavirus vaccine rollout to have a significant advantage Other countries are expected to begin administering doses within weeks, which experts say should provide certainty over any lingering doubts surrounding previously unused mRNA candidates.
What does a new Oxford COVID vaccine trial mean for Australia? The decision comes after doubts emerged over recent trial results that showed greater efficacy with a lower dosage.
Surprise Oxford vaccine results due to manufacturing error Eyebrows were raised when trials showed volunteers who received a lower dose were better protected against COVID-19.
‘The virus respects no borders’: Global COVID vaccine progress gains momentum Amid more promising trial results, G20 leaders – including Australian Prime Minister Scott Morrison – have vowed to ‘spare no effort to protect lives’ and ensure affordable access to vaccines.
Almost 30% of Australians unsure about COVID vaccine – and that’s where GPs come in GPs will play a vital role in reassuring patients about the safety and efficacy of COVID vaccines, according to one expert.
Is two months long enough to monitor for vaccine safety concerns? It is ‘not a straightforward answer’, but experts agree the benefits outweigh the risks.
Vaccine policy identifies priority groups – but order proves ‘contentious’ Healthcare workers will be among the first in Australia to receive any COVID vaccine, but it is not clear if they should be given access ahead of vulnerable groups.